Physician profile
Jeffrey Park
NPI 1124445184
$131,898.19
in general payments reported to CMS, 2019-2025
41 companies · $83K in 2025
The $83K reported for 2025 was more than what 98% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $946 · 2020: $229 · 2021: $18K · 2022: $4,236 · 2023: $5,218 · 2024: $21K · 2025: $83K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $39K · Food and Beverage: $37K · Travel and Lodging: $17K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,600 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $38,860.00 |
| Food and Beverage | $37,320.89 |
| Travel and Lodging | $17,379.79 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,600.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $44,164.39 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Edwards Lifesciences Corporation | $30,230.29 | 2020-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Penumbra, INC. | $24,392.35 | 2022-2025 | Indigo System |
| Medtronic, INC. | $20,523.00 | 2021-2025 | Onyx Frontier, Symplicity G3, Ffrangio |
| Inari Medical, INC. | $3,939.58 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $2,131.77 | 2019-2025 | Watchman Access System, Synergy, Avvigo Guidance System |
| Abiomed | $1,239.16 | 2022-2025 | Impella |
| Heartflow, INC. | $760.07 | 2024-2025 | |
| Abbott Laboratories | $596.24 | 2019-2025 | Navitor, Mitraclip, Triclip |
| W. L. Gore & Associates, INC. | $526.48 | 2021-2025 | Gore Cardioform Septal Occluder |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $397.96 | 2021-2024 | Lifevest |
| Amgen INC. | $358.69 | 2022-2025 | Repatha, Repatha |
| Pfizer INC. | $326.09 | 2022-2025 | |
| Impulse Dynamics (USA) INC. | $213.93 | 2023 | Optimizer |
| Astrazeneca Pharmaceuticals LP | $208.66 | 2023-2025 | Farxiga, Wainua |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $170.16 | 2022 | |
| Novartis Pharmaceuticals Corporation | $148.22 | 2024-2025 | |
| Cvrx, INC. | $146.30 | 2023 | Barostim Neo System |
| Cleerly, INC. | $139.65 | 2024 | Cleerly Ischemia, Cleerly Labs |
| E.R. Squibb & Sons, L.L.C. | $128.44 | 2024-2025 | Camzyos, Eliquis |
| Novo Nordisk INC | $124.81 | 2024 | |
| Merck Sharp & Dohme LLC | $117.61 | 2023-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $114.96 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.96 | 2022-2024 | Jardiance |
| Bridgebio Pharma, INC. | $106.91 | 2025 | Attruby |
| Cardiovascular Systems INC. | $102.89 | 2019 | |
| Alnylam Pharmaceuticals INC. | $77.19 | 2022-2024 | Onpattro |
| Stryker Corporation | $60.50 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sanofi-Aventis U.S. LLC | $52.66 | 2023-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $49.64 | 2024 | Arcalyst |
| Baxter Healthcare | $30.43 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Abbvie INC. | $26.39 | 2023 | |
| Cardinal Health 200 LLC | $26.22 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.92 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $24.61 | 2025 | Opsumit |
| Atricure, INC. | $21.92 | 2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Terumo Medical Corporation | $19.60 | 2019 | |
| Kestra Medical Technology Services, INC. | $17.49 | 2023 | Assure Wcd |
| Lexicon Pharmaceuticals, INC. | $16.96 | 2024 | |
| Philips North America LLC | $16.75 | 2025 | Coronary Other |
| Kiniksa Pharmaceuticals, LTD. | $15.34 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.